Provider messaging is available exclusively during standard business hours
Clinical trials have demonstrated significant efficacy, with patients losing approximately 15% of body weight with semaglutide 2.4 mg (STEP 1 trial) and up to 20% with tirzepatide (SURMOUNT-1 trial) when combined with lifestyle modifications
falciparum 3D7 strain was generally more susceptible to these changes than the resistant Dd2 strain
PlexusDx offers both medications so your clinician can recommend the best fit based on your health history, genetic predispositions, and weight loss goals
Our HQ is located in Tampa Florida
I wonder sometimes, this is my contribution from my field of study, I wonder if the unlearning, even for healthcare professionals, is, people are so resistant to it because of the copious amounts of grief and rage that come with it